Ang et al identified conditions that predict the need for blood component therapy in adults undergoing extracorporeal membrane oxygenation (ECMO) therapy. A patient who is more likely to need transfusion may benefit from more aggressive management that can reduce usage of blood products. The authors are from Singapore General Hospital, the Centre for Transfusion Medicine and National Heart Centre of Singapore.
